David A. Fiellin

David A. Fiellin's AcademicInfluence.com Rankings

David A. Fiellin

Psychology

#3240

World Rank

#3677

Historical Rank

psychology Degrees

David A. Fiellin

Philosophy

#8050

World Rank

#11357

Historical Rank

Logic

#5082

World Rank

#6444

Historical Rank

philosophy Degrees

Download Badge

Psychology
Philosophy

Why Is David A. Fiellin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David A. Fiellin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction (2007) (743)
Screening for alcohol problems in primary care: a systematic review. (2000) (666)
Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. (2015) (568)
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. (2011) (448)
The prevalence and impact of alcohol problems in major depression: a systematic review. (2005) (432)
Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. (2008) (388)
Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. (2007) (333)
Hazardous and harmful alcohol consumption in primary care. (1999) (327)
Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. (2006) (324)
HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study (2011) (234)
Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? (2012) (207)
The Next Therapeutic Challenge in HIV: Polypharmacy (2013) (205)
Gambling: an addictive behavior with health and primary care implications. (2002) (200)
Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. (2014) (199)
The association between marijuana smoking and lung cancer: a systematic review. (2006) (190)
A brief intervention reduces hazardous and harmful drinking in emergency department patients. (2012) (182)
Gender and non-medical use of prescription opioids: results from a national US survey. (2008) (180)
Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention (2017) (173)
Pharmacologic Treatment of Heroin-Dependent Patients (2000) (173)
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis (2020) (168)
Methadone maintenance in primary care: a randomized controlled trial. (2001) (163)
Factors affecting willingness to provide buprenorphine treatment. (2009) (161)
Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. (2014) (146)
Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. (2008) (144)
Primary Care Office-based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent Patients (2007) (144)
Clinical practice. Office-based treatment of opioid-dependent patients. (2002) (143)
Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. (2016) (136)
A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine. (2013) (134)
Principles of addiction medicine (2009) (132)
Brief intervention for hazardous and harmful drinkers in the emergency department. (2008) (131)
Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. (2005) (122)
A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians (2016) (122)
Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons. (2014) (120)
The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment? (2005) (117)
Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program (2010) (116)
Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States (2018) (115)
Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. (2013) (109)
Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy. (2014) (107)
Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study (2009) (107)
Treatment of heroin dependence with buprenorphine in primary care (2002) (106)
Opioids, chronic pain, and addiction in primary care. (2010) (105)
Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults. (2013) (103)
Food Insecurity is Associated with Poor Virologic Response among HIV-Infected Patients Receiving Antiretroviral Medications (2011) (103)
Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department. (2005) (100)
Consensus statement on office-based treatment of opioid dependence using buprenorphine. (2004) (99)
Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlates. (2007) (99)
Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort. (2010) (97)
Cost and utilization outcomes of opioid-dependence treatments. (2011) (95)
Receipt of Opioid Analgesics by HIV-Infected and Uninfected Patients (2012) (93)
New Federal Initiatives To Enhance the Medical Treatment of Opioid Dependence (2002) (92)
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. (2008) (89)
Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents. (2013) (87)
Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study. (2016) (87)
Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone (2011) (87)
A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. (1991) (82)
Food Insecurity and Health: Data from the Veterans Aging Cohort Study (2015) (82)
Cost‐effectiveness of emergency department‐initiated treatment for opioid dependence (2017) (82)
An Evidence-Based Guide to Writing Grant Proposals for Clinical Research (2005) (80)
Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. (2014) (80)
Opioid use disorder in the United States: insurance status and treatment access. (2008) (77)
Primary care physicians' perspectives on the prescription opioid epidemic. (2016) (77)
Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care (2012) (76)
Opioid-Prescribing Practices and Provider Confidence Recognizing Opioid Analgesic Abuse in HIV Primary Care Settings (2011) (75)
A meta-analysis of the efficacy of nonphysician brief interventions for unhealthy alcohol use: implications for the patient-centered medical home. (2011) (74)
Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection. (2011) (74)
Association of Prescribed Opioids With Increased Risk of Community-Acquired Pneumonia Among Patients With and Without HIV (2019) (72)
The epidemiology of substance use disorders in US Veterans: A systematic review and analysis of assessment methods. (2016) (72)
Primary Care Physicians’ Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs (2017) (72)
A trial of integrated buprenorphine/naloxone and HIV clinical care. (2006) (71)
Integration of Buprenorphine/Naloxone Treatment into HIV Clinical Care: Lessons From the BHIVES Collaborative (2011) (70)
Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients (2015) (70)
Outpatient Management of Patients with Alcohol Problems (2000) (68)
Improved Quality of Life for Opioid-Dependent Patients Receiving Buprenorphine Treatment in HIV Clinics (2011) (68)
The association between chronic pain and prescription drug abuse in Veterans. (2009) (68)
Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine (2020) (66)
Increased Hospital and Emergency Department Utilization by Individuals with Recent Criminal Justice Involvement: Results of a National Survey (2014) (66)
The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment (2010) (66)
The First Three Years of Buprenorphine in the United States: Experience to Date and Future Directions (2007) (64)
The Payoff Time: A Flexible Framework to Help Clinicians Decide When Patients With Comorbid Disease are not Likely to Benefit From Practice Guidelines (2009) (62)
Risk for Delirium Tremens in Patients with Alcohol Withdrawal Syndrome (2002) (61)
Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients. (2009) (61)
Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment (2007) (60)
A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition. (1991) (60)
Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America (2017) (59)
Level of Alcohol Use Associated with HIV Care Continuum Targets in a National U.S. Sample of Persons Living with HIV Receiving Healthcare (2018) (58)
Current and Potential Pharmacological Treatment Options for Maintenance Therapy in Opioid-Dependent Individuals (2012) (58)
Women and opioids: something different is happening here (2018) (57)
Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment. (2016) (57)
Perceptions of benefit and risk of patients undergoing first-time elective percutaneous coronary revascularization (2000) (56)
The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence. (2010) (56)
Narrative Review: Buprenorphine for Opioid-Dependent Patients in Office Practice (2008) (56)
Agreement Between Electronic Medical Record-based and Self-administered Pain Numeric Rating Scale: Clinical and Research Implications (2013) (56)
The ASAM Principles of Addiction Medicine (2018) (55)
The effects of federal parity on substance use disorder treatment. (2013) (55)
Office-based treatment for opioid dependence: reaching new patient populations. (2001) (53)
Unhealthy Alcohol and Illicit Drug Use Are Associated With Decreased Quality of HIV Care (2012) (53)
Opioid dependence: rationale for and efficacy of existing and new treatments. (2006) (52)
Improving Adherence to HIV Quality of Care Indicators in Persons With Opioid Dependence: The Role of Buprenorphine (2011) (52)
Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence. (2005) (51)
Unobserved “Home” Induction Onto Buprenorphine (2014) (49)
Nonmedical use of prescription opioids and pain in veterans with and without HIV (2011) (47)
Alcohol Problems and Health Care Services Use in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Veterans (2006) (47)
Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment. (2013) (47)
A randomized trial of primary intensive care to reduce hospital admissions in patients with high utilization of inpatient services. (2006) (47)
Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients. (2018) (46)
Nonmedical use of opioid analgesics obtained directly from physicians: prevalence and correlates. (2011) (45)
The BHIVES Collaborative: Organization and Evaluation of a Multisite Demonstration of Integrated Buprenorphine/Naloxone and HIV Treatment (2011) (45)
Developing and implementing a multispecialty graduate medical education curriculum on Screening, Brief Intervention, and Referral to Treatment (SBIRT). (2012) (45)
Abuse-Deterrent Opioid Formulations - Putting the Potential Benefits into Perspective. (2017) (45)
Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. (2012) (44)
Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV (2016) (44)
New therapies for alcohol problems: application to primary care. (2000) (44)
Office-Based Maintenance Treatment of Opioid Dependence (2008) (44)
Estimating demand for primary care-based treatment for substance and alcohol use disorders. (2016) (44)
An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain. (2019) (44)
Video Game Intervention for Sexual Risk Reduction in Minority Adolescents: Randomized Controlled Trial (2017) (43)
Comparing alcohol screening measures among HIV-infected and -uninfected men. (2013) (41)
Pain and associated substance use among opioid dependent individuals seeking office-based treatment with buprenorphine-naloxone: a needs assessment study. (2013) (40)
Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial. (2010) (40)
Drinking trajectories among HIV-infected men who have sex with men: a cohort study of United States veterans. (2015) (39)
Religion, Spirituality, and HIV Clinical Outcomes: A Systematic Review of the Literature (2018) (39)
Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone. (2012) (39)
HIV/AIDS, comorbidity, and alcohol: can we make a difference? (2010) (39)
Counseling and Directly Observed Medication for Primary Care Buprenorphine Maintenance: A Pilot Study (2012) (38)
Initial strategies for integrating buprenorphine into HIV care settings in the United States. (2006) (37)
Hepatitis C and HIV infections: implications for clinical care in injection drug users. (2004) (37)
Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH) (2019) (36)
Long-term alcohol use patterns and HIV disease severity. (2017) (36)
The physician's role in caring for patients with substance use disorders: implications for medical education and training. (2002) (35)
Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics (2016) (35)
Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients (2015) (35)
Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study. (2017) (35)
The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients. (2014) (35)
State Responses to the Opioid Crisis (2018) (34)
Participant Characteristics and HIV Risk Behaviors Among Individuals Entering Integrated Buprenorphine/Naloxone and HIV Care (2011) (34)
Changes in alcohol use associated with changes in HIV disease severity over time: A national longitudinal study in the Veterans Aging Cohort. (2018) (34)
Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study (2017) (33)
Substance use in older HIV-infected patients. (2014) (33)
Evaluation of a Combined Online and in Person Training in the Use of Buprenorphine (2006) (32)
Innovations in treatment for drug abuse: solutions to a public health problem. (2001) (32)
Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected (2017) (31)
The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/Naloxone (2011) (31)
Incarceration History and Uncontrolled Blood Pressure in a Multi-Site Cohort (2016) (31)
Global opioid agonist treatment: A review of clinical practices by country. (2020) (31)
Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial. (2019) (31)
Number of Drinks to “Feel a Buzz” by HIV Status and Viral Load in Men (2016) (30)
Prevalence and correlates of obstructive sleep apnoea among patients with and without HIV infection (2015) (30)
Treatment of adolescent opioid dependence: no quick fix. (2008) (30)
The Recovery Line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenance. (2013) (29)
Alcohol-Related Diagnoses and All-Cause Hospitalization Among HIV-Infected and Uninfected Patients: A Longitudinal Analysis of United States Veterans from 1997 to 2011 (2016) (29)
Buprenorphine for office-based practice: consensus conference overview. (2004) (28)
Prevalence of unhealthy substance use on teaching and hospitalist medical services: implications for education. (2012) (28)
Provider satisfaction with office-based treatment of opioid dependence: a systematic review. (2006) (28)
Hepatic Safety and Lack of Antiretroviral Interactions With Buprenorphine/Naloxone in HIV-Infected Opioid-Dependent Patients (2011) (27)
Do Alcohol Misuse, Smoking, and Depression Vary Concordantly or Sequentially? A Longitudinal Study of HIV-Infected and Matched Uninfected Veterans in Care (2016) (27)
Antiretroviral Adherence Among Rural Compared to Urban Veterans with HIV Infection in the United States (2012) (27)
Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men (2018) (27)
Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: A systematic review (2013) (27)
The design and implementation of a randomized controlled trial of a risk reduction and human immunodeficiency virus prevention videogame intervention in minority adolescents: PlayForward: Elm City Stories (2016) (26)
Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence. (2007) (26)
Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches? (2008) (26)
Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial (2018) (26)
The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality (2016) (26)
Erectile Dysfunction Drug Receipt, Risky Sexual Behavior and Sexually Transmitted Diseases in HIV-infected and HIV-uninfected Men (2010) (26)
Development of a scale to measure practitioner adherence to a brief intervention in the emergency department. (2012) (26)
Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Alcohol and Other Drug Use Among Adolescents: Evaluation of a Pediatric Residency Curriculum (2012) (25)
Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment (2018) (25)
Recommended Use of Terminology in Addiction Medicine. (2020) (24)
The Cost of Integrated HIV Care and Buprenorphine/Naloxone Treatment: Results of a Cross-Site Evaluation (2011) (24)
Training HIV Physicians to Prescribe Buprenorphine for Opioid Dependence (2006) (24)
Past‐year Prescription Drug Monitoring Program Opioid Prescriptions and Self‐reported Opioid Use in an Emergency Department Population With Opioid Use Disorder (2018) (23)
Comparison of AUDIT-C collected via electronic medical record and self-administered research survey in HIV infected and uninfected patients. (2016) (23)
Opioid substitution therapy—time to replace the term (2015) (23)
What are the Patterns Between Depression, Smoking, Unhealthy Alcohol Use, and Other Substance Use Among Individuals Receiving Medical Care? A Longitudinal Study of 5479 Participants (2017) (22)
Opioid substitution treatment is linked to reduced risk of death in opioid use disorder (2017) (22)
Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study (2018) (22)
Quality of HIV Care and Mortality Rates in HIV-Infected Patients. (2016) (22)
A Research Agenda for Enhancing Appropriate Opioid Prescribing in Primary Care (2013) (21)
AUDIT‐C and ICD codes as phenotypes for harmful alcohol use: association with ADH1B polymorphisms in two US populations (2018) (21)
Guideline-concordant management of opioid therapy among human immunodeficiency virus (HIV)-infected and uninfected veterans. (2014) (21)
Effect of Incarceration History on Outcomes of Primary Care Office-based Buprenorphine/Naloxone (2010) (20)
Alcohol Use (2012) (20)
Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population. (2015) (20)
Processes of care during a randomized trial of office-based treatment of opioid dependence in primary care. (2004) (19)
The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for Three Parallel Multi-Site Stepped Care Effectiveness Studies for Unhealthy Alcohol Use in HIV-Positive Patients. (2017) (19)
Source of prescription drugs used nonmedically in rural and urban populations (2014) (19)
Use of Conventional, Complementary, and Alternative Treatments for Pain Among Individuals Seeking Primary Care Treatment With Buprenorphine-Naloxone (2012) (19)
Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids. (2019) (19)
Predictors of timely opioid agonist treatment initiation among veterans with and without HIV. (2019) (19)
Primary intensive care: pilot study of a primary care-based intervention for high-utilizing patients. (2005) (19)
Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017 (2020) (18)
Past year and prior incarceration and HIV transmission risk among HIV-positive men who have sex with men in the US* (2019) (18)
Depression Symptoms and Treatment Among HIV Infected and Uninfected Veterans (2010) (18)
Measuring alcohol consumption using Timeline Followback in non-treatment-seeking medical clinic patients with and without HIV infection: 7-, 14-, or 30-day recall. (2013) (18)
Limited evidence, faulty reasoning, and potential for a global opioid crisis (2017) (17)
Substance use of disorders in HIV-infected patients: impact and new treatment strategies. (2004) (17)
Guideline Development for Office-Based Pharmacotherapies for Opioid Dependence (2004) (17)
Update in Addiction Medicine for the Primary Care Clinician (2008) (16)
Update in Addiction Medicine for the Generalist (2007) (16)
Comprar The ASAM Principles of Addiction Medicine, 5ª Ed. | Richard K. Ries | 9781451173574 | Lippincott Williams & Wilkins (2014) (15)
Combining Rapid HIV Testing and a Brief Alcohol Intervention in Young Unhealthy Drinkers in the Emergency Department: A Pilot Study (2012) (15)
Sexual Partner Notification of HIV Infection Among a National United States-Based Sample of HIV-Infected Men (2014) (15)
Sex Disparities in Overall Burden of Disease Among HIV-Infected Individuals in the Veterans Affairs Healthcare System (2013) (15)
Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherence. (2015) (15)
Gender and alcohol use: influences on HIV care continuum in a national cohort of patients with HIV (2018) (15)
Association of Alcohol Screening Scores With Adverse Mental Health Conditions and Substance Use Among US Adults (2020) (15)
Patients With Opioid Use Disorder Deserve Trained Providers (2019) (14)
HIV Disease Severity Is Sensitive to Temporal Changes in Alcohol Use: A National Study of VA Patients With HIV. (2019) (14)
Buprenorphine and HIV primary care: new opportunities for integrated treatment. (2006) (14)
Duration of opioid prescriptions predicts incident nonmedical use of prescription opioids among U.S. veterans receiving medical care. (2018) (14)
Accidental drug overdose deaths in Connecticut, 2012-2018: The rise of polysubstance detection? (2019) (14)
Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment (2018) (14)
Failure of Physicians to Prescribe Pharmacotherapies for Addiction : Regulatory Restrictions and Physician Resistance (2014) (14)
Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV. (2020) (13)
Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment (2020) (13)
Substance use in patients with sexually transmitted infections: results from a national U.S. survey. (2010) (13)
Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans. (2019) (13)
Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder. (2020) (13)
Human Immunodeficiency Virus Testing Practices Among Buprenorphine-prescribing Physicians (2012) (13)
Mistrust and Endorsement of Human Immunodeficiency Virus Conspiracy Theories Among Human Immunodeficiency Virus-Infected African American Veterans. (2017) (13)
Alcohol Use and Antiretroviral Adherence Among Patients Living with HIV: Is Change in Alcohol Use Associated with Change in Adherence? (2020) (13)
Reducing Bias in Observational Research on Alcohol Withdrawal Syndrome. (1998) (13)
The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail. (2021) (12)
Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey (2020) (12)
High-dose prescribed opioids are associated with increased risk of heroin use among US military veterans. (2019) (12)
Acetaminophen receipt among HIV‐infected patients with advanced hepatic fibrosis (2013) (12)
The Availability of Ancillary Counseling in the Practices of Physicians Prescribing Buprenorphine (2016) (11)
Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Clinical Trials Network Task Force report (2021) (11)
Safety of Gabapentin Prescribed for Any Indication in a Large Clinical Cohort of 571,718 US Veterans with and without Alcohol Use Disorder (2020) (11)
Association of Syndemic Unhealthy Alcohol Use, Cigarette Use, and Depression With All-Cause Mortality Among Adults Living With and Without HIV Infection: Veterans Aging Cohort Study (2019) (11)
Patterns and Correlates of Prescription Opioid Receipt Among US Veterans: A National, 18-Year Observational Cohort Study (2019) (11)
Patterns of Alcohol Use Among Patients Living With HIV in Urban, Large Rural, and Small Rural Areas. (2018) (11)
One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States (2018) (11)
Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value? (2010) (11)
Association Between Gabapentin Receipt for Any Indication and Alcohol Use Disorders Identification Test—Consumption Scores Among Clinical Subpopulations With and Without Alcohol Use Disorder (2019) (11)
Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine. (2013) (10)
Contemplation of smoking cessation and quit attempts in human immunodeficiency virus-infected and uninfected veterans. (2016) (10)
Racial/ethnic differences in the association between alcohol use and mortality among men living with HIV (2018) (10)
Vaping-Seeking Clarity in a Time of Uncertainty. (2019) (10)
Association Between Risk Behaviors and Antiretroviral Resistance in HIV-Infected Patients Receiving Opioid Agonist Treatment (2013) (9)
DEVELOPING BEST PRACTICES OF EMERGENCY CARE FOR THE ALCOHOL-IMPAIRED PATIENT: RECOMMENDATIONS FROM THE NATIONAL CONFERENCE (2001) (9)
Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder (2022) (9)
Federal Plan for Prescriber Education on Opioids Misses Opportunities (2012) (9)
Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. (2015) (9)
Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta-analysis. (2021) (9)
Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015. (2020) (9)
Women and Opioid Dependence Treatment (2007) (9)
Hazardous drinking and its association with homelessness among veterans in care. (2013) (9)
Alcohol exposure and health services utilization in older veterans. (2000) (9)
Faculty development in small-group teaching skills associated with a training course on office-based treatment of opioid dependence. (2005) (9)
Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trial. (2019) (9)
HIV Testing and Sexual Risk Reduction Counseling in Office-Based Buprenorphine/Naloxone Treatment (2013) (8)
Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment. (2019) (8)
Methadone syrup injection in Australia: a sentinel finding? (2003) (8)
The impact of prescribed opioids on CD4 cell count recovery among HIV‐infected patients newly initiating antiretroviral therapy (2016) (8)
A qualitative study of emergency department patients who survived an opioid overdose: Perspectives on treatment and unmet needs (2020) (8)
Combating the Twin Epidemics of HIV/AIDS and Drug Addiction (2008) (8)
Quality of care for acute myocardial infarction in elderly patients with alcohol-related diagnoses. (2006) (8)
Data resource profile: The Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, Australia. (2020) (8)
Trends in Co-Prescribing of Opioids and Opioid Potentiators Among U.S. Adults, 2007-2018. (2020) (7)
Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward (2018) (7)
More Beds or More Chairs? Using a Science-Based Approach to Address the Opioid Epidemic (2018) (7)
Minority Men Who Have Sex with Men Demonstrate Increased Risk for HIV Transmission (2017) (7)
HIV/AIDS, Comorbidity, and Alcohol (2010) (7)
Measuring Exposure to Incarceration Using the Electronic Health Record (2019) (7)
Emergency department patients with untreated opioid use disorder: A comparison of those seeking versus not seeking referral to substance use treatment. (2020) (7)
Racial/ethnic differences in report of drug testing practices at the workplace level in the U.S. (2014) (7)
Bootstraps and jackknives: new, computer-intensive statistical tools that require no mathematical theories. (1998) (7)
Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001-2018: Findings from the OATS retrospective cohort study. (2020) (7)
Screening for Alcohol Problems in Primary Care (2016) (7)
Buprenorphine: effective treatment of opioid addiction starts in the office. (2006) (7)
The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality (2016) (7)
Marijuana Vaping in U.S. Adults: Evidence From the Behavioral Risk Factor Surveillance System. (2020) (7)
Counseling Requirements for Buprenorphine Maintenance in Primary Care: Lessons Learned From a Preliminary Study in a Methadone Maintenance Program (2004) (7)
Validating Self-Reported Unhealthy Alcohol Use With Phosphatidylethanol (PEth) Among Patients With HIV. (2020) (7)
Physician Detection of Unhealthy Substance Use on Inpatient Teaching and Hospitalist Medical Services (2013) (7)
Treating Pain in Patients Receiving Methadone Maintenance for Opioid Dependence (2013) (7)
Long-term alcohol use patterns and HIV disease severity: A joint trajectory analysis. (2017) (7)
State Variation in AIDS Drug Assistance Program Prescription Drug Coverage for Modifiable Cardiovascular Risk Factors (2011) (7)
The impact of recent cocaine use on plasma levels of methadone and buprenorphine in patients with and without HIV-infection. (2015) (7)
Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report (2020) (6)
The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation. (2021) (6)
Working with HIV clinics to adopt addiction treatment using implementation facilitation (WHAT-IF?): Rationale and design for a hybrid type 3 effectiveness-implementation study (2020) (6)
Mental health after deployment to Iraq or Afghanistan. (2006) (6)
Proliferation of Cash-Only Buprenorphine Treatment Clinics: A Threat to the Nation's Response to the Opioid Crisis. (2019) (6)
Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial (2020) (6)
Impact of defined clinical population and missing data on temporal trends in HIV viral load estimation within a health care system (2015) (6)
Proceedings of the 14th annual conference of INEBRIA (2017) (6)
Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study (2021) (5)
Customized Recommendations and Reminder Text Messages for Automated, Computer-Based Treatment During Methadone (2017) (5)
The case for routine HIV screening and impact of managed care. (2010) (5)
Coordination of Medical Care and Opioid Dependence Treatment in Primary Care: A Case Report (2003) (5)
Readiness to Provide Medications for Addiction Treatment in HIV Clinics: A Multisite Mixed-Methods Formative Evaluation (2021) (5)
Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study (2021) (5)
Substance Abuse and HIV: Treatment Challenges (2010) (5)
A randomized clinical trial of the Recovery Line among methadone treatment patients with ongoing illicit drug use. (2019) (5)
Consumers' Valuation of Primary Care-Based Treatment Options for Mental and Substance Use Disorders. (2015) (5)
Assessing Research Activity and Capacity of Community-Based Organizations: Development and Pilot Testing of an Instrument (2015) (4)
Systematic evidence review on methadone harms and comparative harms (2014) (4)
Health service use in a randomized clinical trial comparing three methods of emergency department interventions for opioid dependence (2015) (4)
Are we missing opioid-related deaths among people with HIV? (2020) (4)
Emergency department‐initiated buprenorphine protocols: A national evaluation (2021) (4)
Impact of behavioral and medication treatment for alcohol use disorder on changes in HIV-related outcomes among patients with HIV: A longitudinal analysis. (2020) (4)
Toward Better Stewardship: Gaining Control Over Controlled Substances (2018) (4)
Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment. (2019) (4)
Models for Implementing Emergency Department-Initiated Buprenorphine with Referral for Ongoing Medication Treatment at Emergency Department Discharge in Diverse Academic Centers. (2022) (4)
Federal plan for prescriber education on opioids misses opportunities. (2012) (4)
A randomized clinical trial of emergency department initiated treatment for opioid dependence: Two and six month outcomes (2015) (4)
Erratum to: Alcohol-Related Diagnoses and All-Cause Hospitalization Among HIV-Infected and Uninfected Patients: A Longitudinal Analysis of United States Veterans from 1997 to 2011 (2015) (4)
Mortality, Health, and Substance Abuse by Religious Attendance Among HIV Infected Patients from the Veterans Aging Cohort Study (2020) (4)
Editorial: Providing Opioid Agonist Maintenance Therapy in a Generalist's Office: The Physician's Perspective (2003) (4)
Association of Poor Mental-Health Days With COVID-19 Infection Rates in the U.S. (2021) (4)
Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV (2021) (4)
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
HIV Infection Prevalence Significantly Intersects With COVID-19 Infection At the Area Level: A US County-Level Analysis (2021) (4)
Does Reducing Drinking in Patients with Unhealthy Alcohol Use Improve Pain Interference, Use of Other Substances, and Psychiatric Symptoms? (2020) (4)
Can Primary Care Practices Help Address the Health Crisis Fueled by Prescription Opioids? (2017) (3)
Bridging the Gap: Dual Fellowship Training in Addiction Medicine and Digestive Diseases (2022) (3)
Incident non-medical use of prescription opioids is associated with heroin initiation among U.S. veterans: A prospective cohort study (2015) (3)
Initial development of patient-reported instrument assessing harm, efficacy, and misuse of long-term opioid therapy. (2016) (3)
Primary care buprenorphine detoxification vs. maintenance for prescription opioid dependence (2015) (3)
100 - Selective Methods Used in Alcohol Research: Screening in Primary Care—Methods and Approaches (2004) (3)
Assessing Research Activity and Capacity of Community-Based Organizations: Refinement of the CREAT Instrument Using the Delphi Method (2019) (3)
Cognitive behavioral therapy improves treatment outcome for prescription opioid users in primary care based buprenorphine/naloxone treatment (2015) (3)
Provider verification of electronic health record receipt and nonreceipt of direct-acting antivirals for the treatment of hepatitis C virus infection. (2018) (3)
A videogame for substance use prevention and HIV risk reduction in young adolescents (2014) (3)
PlayForward: A videogame that increases drug, alcohol and sexual risk knowledge in teens (2015) (3)
Correction to: Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment (2018) (3)
Association of Syndemic Unhealthy Alcohol Use, Smoking, and Depressive Symptoms on Incident Cardiovascular Disease among Veterans With and Without HIV-Infection (2021) (3)
Opioid Treatment for Chronic Back Pain and Its Association with Addiction (2007) (2)
A Case of Kratom Use: Implications for Managing Addiction and Addressing Comorbidity in Overdose Survivors, and for the Education of Clinicians Who Are Not Addiction Specialists (2021) (2)
Group-based medical mistrust and care expectations among black patients seeking addiction treatment (2022) (2)
Physician response to COVID-19-driven telehealth flexibility for opioid use disorder. (2022) (2)
Bringing Harm Reduction into Health Policy - Combating the Overdose Crisis. (2021) (2)
Psychiatric comorbidity and order of condition onset among patients seeking treatment for chronic pain and opioid use disorder. (2021) (2)
Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies. (2022) (2)
260 Perceptions and Experiences of Emergency Department Patients With Opioid Use Disorder (2019) (2)
Corrigendum to "The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients" [Contemp. Clin. Trials 52 (2017) 80-90]. (2017) (2)
Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection. (2016) (2)
Merging statewide data in a public/university collaboration to address opioid use disorder and overdose (2021) (2)
Alcohol Use (2018) (2)
Generalist Physicians and Addiction Care : From Turfing to Sharing the Turf (2001) (2)
Teaching brief intervention for alcohol problems to emergency practitioners: Development, implementation, and testing of a model (2004) (2)
Do brief interventions for unhealthy alcohol use work (2005) (2)
Alcohol Problems: Screening and Management in the Primary Care Setting (1999) (2)
Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment (2022) (2)
Insights Provided by Depression Screening Regarding Pain, Anxiety, and Substance use in a Veteran Population (2020) (2)
Developing an Emergency Department‐Based Intervention to Prevent Opioid Overdose: Listening to Patient Voices: 5EMF (2018) (1)
Project ART-ED: alcohol reduction and HIV testing in the emergency department (2012) (1)
Major depression and recent physical or sexual abuse increase readmissions among high-utilising primary care patients. (2008) (1)
Reply to Ruan et al. (2017): Non-medical use of prescription opioids is associated with heroin initiation among US veterans. (2017) (1)
Effect of Implementation Facilitation to Promote Adoption of Medications for Addiction Treatment in US HIV Clinics (2022) (1)
Associations between obstructive sleep apnea and prescribed opioids among veterans. (2020) (1)
HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years. (2020) (1)
“The devil I know is better than the devil I don’t know”: Enrollment in a pilot trial of opioid dose escalation vs. buprenorphine/naloxone for pain (2017) (1)
The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study (2022) (1)
Using the VACS index to track health outcomes associated with abstinence among HIV-infected patients receiving opioid agonist treatment (2015) (1)
Treatment of Heroin Dependence (2001) (1)
P315: Sexual risk behaviors among minority men who have sex with men with and without HIV (2013) (1)
Rate Your Addiction Treatment Facility: Exploring the Quality Chasm Online (2020) (1)
The development and evaluation of an HIV implementation science network in New England: lessons learned (2021) (1)
Regular article Consensus statement on office-based treatment of opioid dependence using buprenorphine B (2004) (1)
Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV. (2021) (1)
Medical Intensive Care Unit Admission Among Patients With and Without HIV, Hepatitis C Virus, and Alcohol-Related Diagnoses in the United States: A National, Retrospective Cohort Study, 1997–2014 (2019) (1)
Addressing bias in observational studies of alcohol withdrawal syndrome: a call to the field. (2015) (1)
Quality of HIV care and mortality in HIV-infected patients who use drugs and alcohol (2014) (1)
Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder (2023) (1)
Patients With Opioid Use Disorder Deserve Trained Providers (2019) (1)
Analysis of Health Trajectories Leading to Adverse Opioid-Related Events. (2021) (1)
Erratum to: Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV (2017) (1)
Identifying Opioid-Related Electronic Health Record Phenotypes for Emergency Care Research and Surveillance: An Expert Consensus Driven Concept Mapping Process (2022) (1)
Clinical Case Conference: Unobserved “Home” Induction Onto Buprenorphine (2014) (1)
Patient Valuation of different approaches to mental health and Substance use disorder treatment (2015) (1)
Correction to: Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men (2018) (1)
Mortality and guideline-concordant long-term opioid therapy for pain (2015) (1)
W1050 Impact of Alcohol Abuse and Dependence On Liver Fibrosis in a Prospective Cohort of 6090 HIV+/Hiv- U.S. Veterans (2008) (1)
Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIV (2021) (1)
Erratum: Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV (Journal of General Internal Medicine DOI: 10.1007/s11606-009-1164-9) (2010) (0)
Adding buprenorphine implants to counselling reduces opioid use over 6 months in opioid-dependent adults (2011) (0)
Reducing Bias in Observational Research on Alcohol Withdrawal Syndrome (1998) (0)
Grief in Veterans : An Unexplored Consequence of War (2019) (0)
Computational Phenotypes for Patients with Opioid-Related Disorders Presenting to the Emergency Department (2023) (0)
Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl (2023) (0)
Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysis. (2023) (0)
Connecticut statewide addiction medicine/psychiatry grand rounds. (2003) (0)
Do prescribed opioids impact CD4 count restoration among HIV+ patients initiating antiretroviral therapy? (2015) (0)
Opioid prescribing among HIV-infected and uninfected patients (2012) (0)
Assessing Research Activity and Capacity of Community-Based Organizations: Development and Pilot Testing of an Instrument (2015) (0)
P315: Sexual risk behaviors among minority men who have sex with men with and without HIV (2013) (0)
Buprenorphine/naloxone Treatment in Primary Care is Associated with Decreased HIV Risk Behaviors (2008) (0)
Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled Trial. (2023) (0)
Recommendations for Substance Abuse Safety and Engagement at New London Homeless Hospitality Center (2015) (0)
HIV pre-exposure prophylaxis for people who inject drugs: Willingness to prescribe among general internists (2017) (0)
An Automated Screening Strategy to Identify Patients With Alcohol Problems in a Primary Care Setting—Reply (2001) (0)
Perspectives on and experiences of emergency department–initiated buprenorphine among clinical pharmacists: A multi-site qualitative study (2023) (0)
Testing the VACS index as a measure of health outcomes associated with abstinence among patients receiving opioid agonist treatment (2015) (0)
3575 Assessing Research Activity and Capacity of Community Based Organizations: Field Testing of the Community Research Activity Assessment Tool (CREAT) (2019) (0)
Availability of Specific Programs and Medications for Addiction Treatment to Vulnerable Populations: Results from the Addiction Treatment Locator, Assessment, and Standards (ATLAS) Survey. (2023) (0)
Patients' perspectives of medications for addiction treatment in HIV clinics: A qualitative study. (2022) (0)
Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics (2022) (0)
Opioid Doses and Increased Risk for Overdose. Authors' reply (2010) (0)
Prescriber Education on Opioids (2012) (0)
Receipt of opioid therapy guideline- concordant care among HIV+ and HIV− veterans (2015) (0)
Commentary Article: Strategic Planning for Addiction Programs within Academic Medical Centers: Examples from the Yale Program in Addiction Medicine (2022) (0)
SOAPs and SUDs: Patients With Substance Use Disorders and What Clinicians Should Know About the Cures Act. (2021) (0)
Willingness to enter drug treatment: The role of treatment models, copays and financial incentives (2015) (0)
Erratum to: Erectile Dysfunction Drug Receipt, Risky Sexual Behavior and Sexually Transmitted Diseases in HIV (2010) (0)
Prescribing opioids safely in the emergency department study: Predictors of emergency department discharge with high morphine milligram equivalent prescription (2017) (0)
SU137DIFFERENCES DETWEEN AUDIT-C AND AUD PHENOTYPES REVEALED BY GENOME-WIDE ANALYSIS (2019) (0)
Opioid Dependence Treatment in the Emergency Department--Reply. (2015) (0)
237 Urine Toxicology Profiles of Adult Emergency Department Patients With Untreated Opioid Use Disorder: National Data from 26 Emergency Departments (2021) (0)
221 Changes in Emergency Department Visits for Opioid-Related Diagnosis, Opioid Overdose and Buprenorphine Use Across 14 US Emergency Departments During the SARS-CoV-2 Pandemic (2021) (0)
Buprenorphine Initiation in the Era of High-Potency Synthetic Opioids: A Call for Community-Based Participatory Research to Help Learning Health Systems Provide Precision Medicine for Opioid Use Disorder. (2022) (0)
Treatment of Unhealthy Alcohol Use (2019) (0)
Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary-Care Based Buprenorphine Treatment (2016) (0)
Reply to Marcellin et al. (2014) (0)
Receptiveness To Smoking Cessation Among HIV-Infected And Uninfected Patients (2012) (0)
Proceedings of the 13th annual conference of INEBRIA (2016) (0)
Reply to Letter “Additional Explanation for Lack of Pharmacodynamic Interaction Between Atazanavir and Buprenorphine Reported by Vergara-Rodriquez et al” (2011) (0)
Association of Topiramate Prescribed for any Indication with Reduced Alcohol Consumption in Electronic Health Record Data (2022) (0)
Dose and other factors associated with decreased pain intensity among patients initiating buprenorphine/naloxone (2015) (0)
Health risk behaviors and injured patients: an exploratory study (2010) (0)
2224. Receipt and Virologic Outcomes of HCV Direct-Acting Antivirals by Alcohol Use and HIV Status (2018) (0)
199 Extended-Release Injectable Buprenorphine for Emergency Department Patients with Opioid Use Disorder in Minimal Withdrawal (2021) (0)
Beyond diagnosis: patient mix and challenges to patient care in ambulatory training sites. (2000) (0)
Efficacy of Brief Interventions for Hazardous and Harmful Drinkers in the Emergency Department: (706182011-001) (2011) (0)
Outcomes of Patients with Opioid-Related Diagnoses in Acute Coronary Syndrome: a National Inpatient Sample-Based Analysis (2022) (0)
Alcohol use and sustained virologic response to hepatitis C virus direct-acting antiviral therapy: a national observational cohort study (2022) (0)
159 Implementing Emergency Department-Initiated Buprenorphine in Low-Resource, High-Need Settings (2019) (0)
The Relationship Between Drinking Behavior and Conversational Processes During a Brief Alcohol Reduction Intervention for People with HIV (2022) (0)
Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States. (2023) (0)
Reply to Osborne & Serdarevic (2017): Potential impact of exposure definition when examining non-medical use of prescription opioids among US veterans. (2017) (0)
Opioid Doses and Increased Risk for Overdose (2010) (0)
Missed Opportunities for HIV and Hepatitis C Screening Among Emergency Department Patients With Untreated Opioid Use Disorder (2022) (0)
Editorial (2003) (0)
Federal parity does not lead to large increases in spending on substance use disorder treatment: Results from year 1 (2014) (0)
Patient Selection and Baseline Characteristics : Are Some Patients More Appropriate for Unobserved Induction ? (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David A. Fiellin?

David A. Fiellin is affiliated with the following schools:

Yale University

David A. Fiellin's Academic­Influence.com Rankings

Why Is David A. Fiellin Influential?

David A. Fiellin's Published Works

Published Works

What Schools Are Affiliated With David A. Fiellin?

David A. Fiellin's AcademicInfluence.com Rankings